A significant new study has revealed a worrying link between obesity and infectious diseases, indicating that individuals living with obesity face a substantially higher risk of experiencing severe outcomes from infections like the flu, COVID-19, pneumonia, and gastroenteritis. The research, published in the esteemed medical journal The Lancet, found that the chances of hospitalisation or even death due to these common illnesses are markedly increased for those with higher body mass index (BMI).
Solja Nyberg, a lead author of the study from the University of Helsinki, expressed concern that as global obesity rates continue to climb, so too will the number of fatalities and hospital admissions directly attributable to infectious diseases exacerbated by obesity. This underscores the urgent need for robust public health policies. Nyberg emphasised that to mitigate these risks, alongside other health complications associated with obesity, proactive measures are essential. These include promoting healthy lifestyles, supporting weight loss efforts, ensuring access to affordable, nutritious food, and creating more opportunities for regular physical activity.
Unpacking the Research: Data and Findings
The comprehensive study delved into extensive datasets, analysing information from over 67,000 adults in Finland and a substantial cohort of more than 470,000 adults from the UK Biobank. The primary aim was to meticulously examine the intricate relationship between obesity and the severity of infectious diseases.
Participants were initially categorised based on their BMI at the commencement of the study: a healthy weight group, an overweight group, and an obese group. Within the obese category, further classifications were made based on the severity of obesity: Class I (BMI of 30–34.9 kg/m²), Class II (BMI of 35–39.9 kg/m²), and Class III (BMI of 40 kg/m² or higher). The participants were then monitored for an average period of 13 to 14 years, allowing for a thorough observation of health outcomes.
Key Findings: A Stark Increase in Risk
The research yielded a stark and significant finding: individuals classified as obese exhibited a 70 percent greater risk of hospitalisation or death from any infectious disease when compared with their counterparts who maintained a healthy weight (BMI between 18.5 and 24.9).
Furthermore, the study observed a consistent and escalating trend in risk as body weight increased. Those individuals with the most severe form of obesity, defined as a BMI of 40 kg/m² or above, faced a threefold increased risk compared to individuals with a healthy weight.
Mika Kivimäki, who led the study at University College London, commented on these findings, suggesting that the fact obesity acts as a risk factor across such a broad spectrum of infectious diseases points towards underlying biological mechanisms that may be broadly applicable. He posited that it is highly probable that obesity compromises the immune system’s capacity to effectively combat infectious agents such as bacteria, viruses, parasites, and fungi. This weakened defence can consequently lead to more severe illness.
However, Kivimäki also stressed that further investigation is necessary to definitively confirm the precise biological pathways that underpin these observed associations.
Limitations and Global Implications
It is important to acknowledge the limitations inherent in the study’s design. As an observational study, it establishes correlations rather than direct cause-and-effect relationships. The researchers also pointed out that the reliance on BMI as the primary metric did not fully account for other crucial factors such as the distribution of body fat or the presence of metabolic dysfunction, both of which can influence health outcomes.
Despite these limitations, the implications of the study on a global scale are considerable. By applying the calculated risk ratios to worldwide data on obesity prevalence and infectious disease mortality, the researchers estimated that a significant proportion of infection-related deaths globally – ranging from 9 to 11 percent – could potentially be averted if obesity were eliminated.
The burden of obesity-related infectious disease deaths varies considerably by country. In the United States, a striking 25.7 percent of infection-related deaths are linked to obesity, representing the highest percentage globally. Spain follows with 21.2 percent, the United Kingdom with 17.4 percent, and Germany with 14.7 percent. In contrast, India and China reported the lowest burden, at 9 percent and 3.8 percent respectively.
The Rising Tide of Obesity in Europe
The issue of rising obesity rates is particularly acute across Europe. According to data from the European Union, approximately 17 percent of European adults are obese, and a further 51 percent are overweight. The World Health Organization (WHO) has characterised this situation as an “obesity epidemic.”
European nations had aimed to halt the increase in adult obesity at 2010 levels by the year 2025. However, this target has not been met by any European country, with obesity rates having surged by a staggering 138 percent since 1975.
More recent strategic objectives, outlined in the 2022–2030 Non-Communicable Diseases Action Plan, include a more ambitious goal: a 30 percent relative reduction in average BMI by 2030. Crucially, this plan also includes specific measures to halt the rise in childhood obesity.
